Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. News
  7. Summary
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
Delayed Quote. Delayed Nasdaq - 01/14 04:00:00 pm
110.82 USD   -1.39%
01/14COVID still a serious threat, warn German health officials
RE
01/14Top Premarket Decliners
MT
01/13South Korea to deploy Pfizer COVID-19 pills as Omicron wave looms
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Novavax

12/02/2021 | 05:30pm EST


ę MT Newswires 2021
All news about NOVAVAX, INC.
01/14COVID still a serious threat, warn German health officials
RE
01/14Top Premarket Decliners
MT
01/13South Korea to deploy Pfizer COVID-19 pills as Omicron wave looms
RE
01/12South Korean Regulator Approves Novavax COVID-19 Vaccine
MT
01/12GLOBAL MARKETS LIVE : Boeing, J Sainsbury, Exxon Mobil, Sony, Apple...
01/12Today on Wall Street: Powell worked its magic
01/12Novavax COVID-19 Vaccine Secures Clearance In South Korea
MT
01/12South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
PR
01/12South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
CI
01/12South Korea Approves Novavax COVID-19 Vaccine; to Start Distribution of Pfizer Pills
MT
More news
Analyst Recommendations on NOVAVAX, INC.
More recommendations
Financials (USD)
Sales 2021 1 378 M - -
Net income 2021 -919 M - -
Net cash 2021 756 M - -
P/E ratio 2021 -9,01x
Yield 2021 -
Capitalization 8 379 M 8 379 M -
EV / Sales 2021 5,53x
EV / Sales 2022 1,53x
Nbr of Employees 792
Free-Float -
Chart NOVAVAX, INC.
Duration : Period :
Novavax, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVAVAX, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 110,82 $
Average target price 270,00 $
Spread / Average Target 144%
EPS Revisions
Managers and Directors
Stanley C. Erck President, Chief Executive Officer & Director
James Patrick Kelly Chief Financial Officer, Treasurer & Executive VP
James F. Young Chairman
Gregory M. Glenn President-Research & Development
Biegie Lee Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
NOVAVAX, INC.-22.54%8 379
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684